Always have a benefit of doubt, but kena minum kopi by MACC, really hard to say now

No more legend story after the ex-management.

Seems useful for my company, Hope to get more details on this system.

Be fearful when others are greedy. Be greedy when others are fearful.

Such a good time

推销? 我觉得没有人会那么无聊啦。 毕竟支持者还是有， 风来了，借趋势短炒也不错。
毕竟没有道理的东西，一下就会被写盖掉了。

Plus additional that all previous contract not fully reflect in QR which I think if sooner or later profit, the share price will like rocket aldi
(Disclaimer : not a buy call, just personal opinion）

In this case, I think work in both way la. Now warrant wanna expire, sure will have another wave of goreng la. Bio pattern when come with news, got chance to spike high.

lol. fight with solarvest ? not same level la, but honest speaking according the post is right. Rebound sign is coming and FAST quiet for sometime already. Maybe a big rebound is coming soon. Short play can la, Long hold still Solarvest

Anyhow Nice and comfortable mask for kanger and not expensive

https://commonmask.co/products/common

Every time I comes kanger also that few people commenting only.

All work as pure spammer ke ?

hahaha, Then i would rate whistlebower99 most strong spammer, cause when pass by some counter can see same info, same thing, same newbie post.

I also started to feel is him a real joker.

Guess everyone know that who comment here not old folks also got some experience already la. To avoid or not avoid don't need your 【FOR NEW NEWBIES】post. Write something new la, Nothing write still want comment? Work for KPI as a spammer meh ? Boring af.

如果不能长期持有就做短期， 像bioholding 这种，可以借趋势购买的

自己买股，自己负责。 连harta 都给你吹。 不是没有好股了 ？

@Kilimwy you should look ahead for the longterm, currently just some small sparks which doesn't affect the performance of DNONCE much

DNONCE definitely still fundamentally strong, pls hold on for those that are gonna invest for long term

Very premium feel ~~~~

this news not so fresh. Look at this.
https://www.nst.com.my/business/2021/08/722649/kanger-ventures-manufacturing-sales-surgical-face-masks

Something brewing ?

Seems that coming QR , bioalpha will reflect a good outcome

https://www.theedgemarkets.com/article/bioalpha-seeks-break-south-sudan-covid19-test-market

KUALA LUMPUR (July 28): Bioalpha Holdings Bhd has partnered a laboratory in South Sudan to undertake a Covid-19 testing programme at the border entry points in the country.

The health supplement group said in a filing that its wholly-owned subsidiary Bioalpha (HK) Ltd (Bioalpha HK) had entered into a memorandum of agreement (MoA) with Crawford Laboratory of the Republic of South Sudan to exclusively undertake the Covid-19 testing programme.

The mandate involves installation of testing facilities, as well as the provision of testing products and services at border entry points in the country to screen all inbound travellers to South Sudan at these locations to prevent cross-border infections.

According to Bioalpha, this collaboration is part of the initiative by the East African Community (EAC) to make available Covid-19 testing products and services to the 180 million population in six partner countries.

Apart from South Sudan, the other countries are Kenya, Rwanda, the United Republic of Tanzania, the Republic of Uganda and the Republic of Burundi.

Crawford Laboratory is principally involved in the provision of Covid-19 testing activities in South Sudan and is currently the only organisation in the country offering online applications for Covid-19 tests.

Under the MoA, Bioalpha HK will supply the necessary equipment and the training required to properly utilize the said equipment for the purpose of the Covid-19 testing programme.

Bioalpha HK will supply 100,000 test kits per month along with its consumables, and the testing cost to be charged to travellers is at approximately US$20 (RM85) for locals and US$50 (RM212) for foreigners.

Meanwhile, Crawford Laboratory will manage the testing facilities and liaise with the necessary authorities within South Sudan to ensure all inbound travellers to the country via the Nimule and Juba International Airport are compulsorily required to take the Covid-19 test under the programme.

It will also obtain the necessary regulatory approvals required for the programme.

The MoA will come into effect on the date of signing and will remain in effect for a period of two years from the date of signing of the MoA subject to a further renewal based on both parties' mutual agreement.

Bioalpha said the MoA enables the company to widen its revenue streams to include the distribution of Covid-19 screening equipment and products to nations under the EAC, starting with South Sudan, which has a population of 11 million people.

“In addition, this programme would also pave way and serve as a platform for Bioalpha to expand the delivery of other healthcare and pharmaceutical products and services to South Sudan as well as other partner states under the EAC,” it said, adding that this opens up a whole new market for Bioalpha as it establishes its presence in the EAC nations.

The MoA is expected to contribute positively towards the future earnings of Bioalpha, the company said.

Bioalpha closed 0.5 sen or 2.27% higher at 22.5 sen today, valuing the group at RM260.59 million.

https://klse.i3investor.com/blogs/highrewardking/2021-07-10-story-h1567918297-Upbeat_Earnings_Moving_Ahead_Kanger_International_Berhad.jsp

One of the quickest and most effective way of gauging if a company is “trustworthy” would be on the act of its management. This is fairly straightforward, given that if the management owns a huge chunk of share in the company, the ultimate reward – in share price would benefit them as long as they performed well.

Recently, Kanger International Berhad (0170) two good news to be announced. The first one being the company had received an extension of time granted by Ganzhou Bank Co., Ltd for the repayment of RMB60 million loan. So far, KANGER had only repaid RMB8 million in the loan.

The extension of repayment signifies a vote of confidence from Ganzhou Bank Co., Ltd to KANGER, which I expect them to have interesting stories moving forward.


Next, if we backdate to 26th April 2021, KANGER had also ventured into a share sale agreement with Sii family to purchase 51% stake of Sung Master Holdings Sdn Bhd for a total consideration of RM94.8 million.

As we mention earlier, one of the best way to gauge the trustometer of a company is the act of the management.


Under ordinary resolution 1 for KANGER’s upcoming EGM, the company proposed to complete the acquisition exercise of the building material supplier Sung Master. The way of settlement would be RM51.9 million in cash and RM42.7 million in new shares issuance.


Of course, issuance of new shares is not a problem for the company. How about the cash part?


In KANGER’s latest quarterly report, it clearly shows that the company had more than enough cash for the settlement of the purchase.


But the management would take this acquisition to another level.


As you can see, under the ordinary resolution 2 of the company, the existing key management and shareholder of the company – Mr. Kuah Choon Ching had showed an additional vote of confidence by agreed to subscribe 769,513,179 shares at 6 cents each to fund the acquisition.


In short, Mr. Kuah is very confident in the acquisition to invest over RM40 million into the acquisition.


Also, KANGER’s share price had actually bottomed at the current level. It seems like all risks are extremely low for now. What are your thoughts on the company?

This is my personal view la

But I think most people rather pay for not queening in such crowded place.

But government processing is a little slow. That's why they involve in pakatan harapan to assist on their vaccine and recently i had also realize there are most venue setting vaccine area.

Is time to ride to the sky

hmmm, nothing special now

God knows that can make it wellington steak set. hhahaah, seems some vaccine counter already start moving

insider news here, kanger gonna limit up very very soon

kanger gonna expand his business to sabah & sarawak, and more vaccine shipment in June, better leave yongtai who does nothing for the whole 6 month

I heard that kanger going to boom soon as recent vaccine is start on going. later after lunch going to fly ? They are on going to start on sabah if not be wrong, Saw this on a telegram group.

Seems like the previous wave that push to 55, dnonce now strong support at 52. Got chance to push to 58 and on going again.

1. Dnonce Berhad是一间总部设立在槟城的上市公司，其现今主要业务是为医疗行业提供PACKAGING和Carton Box的供应，和提供无尘室专案服务(Cleanroom), 为电子代工(EMS)和HDD&SSD业者服务。

2. 公司成立至今已有三十年，一开始从槟城起家慢慢扩展至全马和泰国。其厂房和生产下如下：

I Penang Prai, packaging和CLEANROOM服务,服务主要是电子行业和HDD
II. KL Cheras, 制作PCB 配件
III. KB Kelantan & JB Kulai, 生产carton Box
IV.泰国 Sadao, 生产carton box,主要服务于手套业
V 泰国 Uthai, 提供cleanroom 方案服务

3. 公司在八月底公布了F2021Q1令人刮目相看的业绩。其单季度的净利表现就超过了自2015年全年财政年的净利总和，其单季度净利来到了3.8M。公司营业额主要贡献来自于医疗行业的客户，也就是手套行业业者(15.7m),和科技电子业业者(25.1m)。剩余10%则来自于其它业务。在毛利(GP)方面，医疗行业的贡献反而科技电子行业来的更高，占了整体毛利的50%。

4. 公司成长因素有几点。第一，公司受惠于医疗行业，其在医疗行业最大的客户群就是手套行业。在全球最大的手套生产国就是马来西亚和泰国， 而公司的生产基地就在这两个国家。在2007年，分公司在Sadao购置了20Acre的土地，而公司现阶段只利用了2Acre的土地就贡献了现今的生意量。也就是说，随着手套医疗需求在未来明显增长，公司可以充分利用剩余的18Acre土地来增加其厂房来应对日益增长的需求。公司在泰国业务的市场份额大概占了30%左右，另外70%份额由另外两家所消化。业主不会单单只让其中一家所承包，也就是说产量需求只会持续增加

5. 其二，公Cleanroom service也受惠在这次疫情事件。由于疫情导致对于科技产品的需求尤其是HDD的需求量增加，加上中美冲突致使越来越多电子代工行业搬迁来东南亚，而相对疫情稳定的马来西亚就是他们的首选，而这些业者对于Cleanroom setup需求是相当大的。整体来说，市场对于Cleanroom service的需求量是很大的。

6. 其三，公司自聘用了Mr Tho Yow Yin为公司的CEO后，业绩开始就开始突发猛进。据可靠消息，有本地手套业者已要求公司在设立新工厂供应carton box给他们，起码两年衣食无忧。

7. 估值方面，假设每个季度能保持在4m的净利的话，全年的净利将会是16m， 相当于EPS 6.2cents。以如今股价62.5cents来看，forward PE才10。以包赚行业来看，平均PE是15-20左右。以此来看，上升空间值得期待。

This is a post from a blogger - (Post time end of the year 2020) .
However if you compare back the current stock price.
Definitely Dnonce is undervalue on current stage which so big gap to extend.

with more project announced at 2020, expeciting good result for next quarter too

not yet announced, how to see it lol